Is HIV part of the picture?
That matters because the approved use is tied to adults with HIV and lipodystrophy.
Look past “peptide”
What tesamorelin is—and is not
Start with the label, meaning the FDA-approved instructions that say exactly what a medicine is for. The broad word “peptide” tells you much less.
Checklist
The short version
Read these notes in order.
What it is
Tesamorelin is a lab-made form of a natural signal called growth hormone-releasing hormone.
What it does
It tells the pituitary gland, a pea-sized gland under the brain, to release more of the body’s own growth hormone. That raises IGF-1, a substance in the blood that goes up when growth hormone goes up.
What the label covers
As of September 2026, its FDA-approved use is reducing extra belly fat in adults with HIV and lipodystrophy.
What lipodystrophy means here
It is a shift in body fat that can happen with HIV treatment.
What the label leaves out
As of September 2026, the label says tesamorelin is not a medicine for weight-loss management.
Strung-together amino acids, a few links long, make a peptide; proteins use those very links, just many more of them. That word alone says nothing about approval or fit.
Compare
Three questions that change the route
The same search can hide very different needs.
Is the goal weight loss?
That goal falls outside the tesamorelin label.
Is the product clearly named?
Approved tesamorelin and a “research” vial are not the same care path.